Analyze the Clinical Process, Regulatory Landscape and Market Competition to Maximize Commercial Potential
- Washington, District of Columbia
Available for $495.00
Position Yourself for Commercial Success in the Evolving Biosimilars Landscape – Implications and Applications for Biosimilar and Innovator Companies
The long-awaited FDA guidance on biosimilars has finally been released, but the industry is far from having all of their questions answered. Understanding the regulatory and commercial realities of the biologics market is crucial for educating HCPs and payers to safely introduce biosimilars into the U.S. healthcare system. Our summit places unique focus on the assessment of market access, strategies for effective commercialization and options for interchangeability. Join us to explore the current climate for biosimilars business and evaluate competition, reimbursement strategies and patient safety.
This interactive forum covers:
- The impact of FDA guidance on the biosimilar pathway
- Lessons learned from biosimilar development in Europe
- Commercial strategies for marketing biosimilars
- Biosimilar pricing schemes and market access barriers
- Immunogencity challenges with interchangeability
- Implications of biosimilarity for labeling and nomenclature
